Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease

Experimental Neurology

Volumn 150, Issue 1, 1998, Pages 40-44

  Marcus, David L ^a   Thomas, Christopher ^a   Rodriguez, Charles ^a   Simberkoff, Katherine ^a   Tsai, Jir S ^a   Strafaci, James A ^a   Freedman, Michael L ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Antioxidation; Peroxidation; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGED; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CEREBELLUM CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 0032031780     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6750     Document Type: Article

References (32)

1. Harman D. Free radical theory of aging. Age. 16:1993;23-30.
2. Volicer M. Free radicals in the development of Alzheimer's disease. Neurobiol. Aging. 11:1990;567-571.
3. Southorn P. A., Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clinic Proc. 63:1988;381-389.
4. Halliwell B., Gutteridge J. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1984;1-14.
5. Dunford H. B. Free radicals in iron-containing systems. Free Rad. Biol. Med. 3:1987;405-421.
6. Terry R. D., Masliah E., Salmon D., Butters N. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
7. Marcus D. L., Thomas C., Freedman M. Peroxidation and superoxide dismutase activity in Alzheimer's disease. J. Am. Ger. Soc. 41:1993;SA9.
8. McKann G., Drachman D., Folstein M. Clinical diagnosis of Alzheimer's disease. Neurology. 34:1984;939-944.
9. Subbarao K. V., Richardson J. S., Ang L. Autopsy samples of Alzheimer's cortex show increase peroxidation in vitro. J. Neurochem. 55:1990;342-345.
10. Geremia E., Baratta D., Zafarana S., Giordano R. Antioxidant enzymatic systems in neuronal and glial cell-enriched fractions of the rat brain during aging. Neurochem. Res. 15:1990;719-723.
11. Kostyuk V. A., Potapovich A. I. Superoxide driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem. Int. 19:1989;1117-1124.
12. Aebi H. Catalase in vitro. Methods Enzymol. 105:1984;121-126.
13. Paglia D. E., Valentine W. M. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
14. Furata A., Price D. L., Troncoso J. C. Localization of superoxide dismutase in Alzheimer's disease and down's syndrome neocortex and hippocampus. Am. J. Pathol. 146:1995;357-367.
15. Mizuno Y., Ohta K. Increased lipid peroxidation and superoxide dismutase activity in adult and aged brain. J. Neurochem. 46:1986;1344-1352.
16. Sulkava R., Nordberg U.-R. Red cell superoxide dismutase in Alzheimer's disease and other dementias. Acta Neurol. Scand. 73:1986;487-489.
17. Chen L., Richardson J. S., Caldwell J. E., Ang L. C. Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int. J. Neurosci. 75:1994;83-90.
18. Richardson J. S. Free radicals in the genesis of Alzheimer's disease. Ann. N.Y. Acad. Sci. 695:1993;73-76.
19. Balazas L., Leon M. Evidence of an oxidative challange in the Alzheimer's brain. Neurochem. Res. 19:1994;1131-1137.
20. Gsell W., Conrad R., Hicketheir M., Sofic E., Frolich L. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem. 64:1995;1216-1223.
21. Terry R. D., MAsliah E., Salmon D. P. Physical basis of cognitive alterations in Alzheimer's disease. Ann. Neurol. 30:1991;572-580.
22. McKee A. C., Kosik K. S., Kowall N. W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:1991;156-165.
23. Terry R. D., Davies P. Dementai of the Alzheimer's type. Annu. Rev. Neurosci. 3:1980;77-95.
24. Brun, A. 1983, Pathological features of Alzheimer's disease: An overview of light and electron microscopic changes, Alzheimer's Disease: The Standard Reference, 37, 47, Free Press, New York.
25. Price D. L., Davis P. B., Morris J. C., White D. L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12:1991;295-312.
26. Arrigada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
27. Kato K., Kurobe N., Suzaki R. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease. J. Mol. Neurosci. 3:1991;95-99.
28. Jeandel C., Nicolas M. B., Dubois F., Nabet-Belleville F., Penin F., Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology. 35:1989;275-282.
29. Andorn A. C., Britton R. S., Bacon B. R. Evidence that lipid peroxidation and total iron is increased in Alzheimer's brain. Neurobiol. Aging. 11:1990;316.
30. Marcus D. L., de Leon M. J., Goldman J. Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann. Neurol. 26:1989;91-94.
31. de Leon M. J., Ferris S. H., George A. E. Positron emission tomography studies of aging and Alzheimer's disease. Am. J. Neuroradiol. 4:1983;568-571.
32. Pardridge W. Glucose transport and phosphorylation: Which is rate limiting for brain glucose utilization. Ann. Neurol. 35:1994;511-512.